参考文献/References:
[1] DOLGIN E.The myopia boom[J].Nature,2015,519 (7543):276-278.
[2] HOLDEN B A,FRICKE T R,WILSON D A,JONG M,NAIDOO K S,SANKARIDURG P,et al.Global prevalence of myopia and high myopia and temporal trends from 2000 through 2050[J].Ophthalmology,2016,123(5):1036-1042.
[3] FLITCROFT D I,HE M,JONAS J B,JONG M,NAIDOO K,OHNO-MATSUI K,et al.IMI-defining and classifying myopia:a proposed set of standards for clinical and epidemiologic studies[J].Investig Opthalmol Vis Sci,2019,60(3):M20-M30.
[4] BULLIMORE M A,BRENNAN N A.Myopia control:why each diopter matters[J].Optom Vis Sci,2019,96(6):463-465.
[5] ENTHOVEN C A,TIDEMAN J W L,POLLING J R,TEDJA M S,RAAT H,IGLESIAS A I,et al.Interaction between lifestyle and genetic susceptibility in myopia:the generation R study[J].Eur J Epidemiol,2019,34(8):777-784.
[6] JONES L A,SINNOTT L T,MUTTI D O,MITCHELL G L,MOESCHBERGER M L,ZADNIK K.Parental history of myopia,sports and outdoor activities,and future myopia[J].Invest Ophthalmol Vis Sci,48(8):3524-3532.
[7] KLAVER C C W,POLLING J R,ENTHOVEN C A.2020 as the year of quarantine myopia[J].JAMA Ophthalmol,2021,139(3):300-301.
[8] HU Y,ZHAO F,DING X,ZHANG S,LI Z,GUO Y,et al.Rates of myopia development in young Chinese schoolchildren during the outbreak of COVID-19[J].JAMA Ophthalmol,2021,139(10):1115-1121.
[9] FRICKE T R,JONG M,NAIDOO K S,SANKARIDURG P,NADUVILATH T J,HO S M,et al.Global prevalence of visual impairment associated with myopic macular degeneration and temporal trends from 2000 through 2050:systematic review,meta-analysis and modelling[J].Br J Ophthalmol,2018,102(7):855-862.
[10] VONGPHANIT J,MITCHELL P,WANG J J.Prevalence and progression of myopic retinopathy in an older population[J].Ophthalmology,2002,109(4):704-711.
[11] BAILEY M D,OLSON M D,BULLIMORE M A,JONES L,MALONEY R K.The effect of LASIK on best-corrected high-and low-contrast visual acuity[J].Optom Vis Sci Off Publ Am Acad Optom,2004,81(5):362-368.
[12] WU P C,CHEN C T,CHANG L C,NIU Y Z,CHEN M L,LIAO L L,et al.Increased time outdoors is followed by reversal of the long-term trend to reduced visual acuity in Taiwan primary school students[J].Ophthalmology,2020,127(11):1462-1469.
[13] LINGHAM G,YAZAR S,LUCAS R M,MILNE E,HEWITT A W,HAMMOND C J,et al.Time spent outdoors in childhood is associated with reduced risk of myopia as an adult[J].Sci Rep,2021,11(1):6337.
[14] ROSE K A,MORGAN I G,IP J,KIFLEY A,HUYNH S,SMITH W,et al.Outdoor activity reduces the prevalence of myopia in children[J].Ophthalmology,2008,115(8):1279-1285.
[15] YANG X,YANG Y,WANG Y,WEI Q,DING H,ZHONG X.Protective effects of sunlight exposure against PRK-induced myopia in infant rhesus monkeys[J].Ophthalmic Physiol Opt,2021,41(4):911-921.
[16] GUO Y,LIU L,LV Y,TANG P,FENG Y,WU M,et al.Outdoor jogging and myopia progression in school children from rural Beijing:the Beijing children eye study[J].Transl Vis Sci Technol,2019,8(3):2.
[17] CHO P,TAN Q.Myopia and orthokeratology for myopia control[J].Clin Exp Optom,2019,102(4):364-377.
[18] CHO P,CHEUNG S W.Retardation of myopia in Orthokeratology (ROMIO) study:a 2-year randomized clinical trial[J].Invest Ophthalmol Vis Sci,2012,53(11):7077-7085.
[19] CHEN R,YU J,LIPSON M,CHEEMA A A,CHEN Y,LIAN H,et al.Comparison of four different orthokeratology lenses in controlling myopia progression[J].Contact Lens Anterior Eye,2020,43(1):78-83.
[20] HIRAOKA T,KAKITA T,OKAMOTO F,TAKAHASHI H,OSHIKA T.Long-term effect of overnight orthokeratology on axial length elongation in childhood myopia:a 5-year follow-up study[J].Invest Ophthalmol Vis Sci,2012,53(7):3913-3919.
[21] ZHU M J,FENG H Y,HE X G,ZOU H D,ZHU J F.The control effect of orthokeratology on axial length elongation in Chinese children with myopia[J].BMC Ophthalmol,2014,14:141.
[22] CHARM J,CHO P.High myopia-partial reduction orthokeratology (HM-PRO):study design[J].Contact Lens Anterior Eye,2013,36(4):164-170.
[23] KANG P,SWARBRICK H.Peripheral refraction in myopic children wearing orthokeratology and gas-permeable lenses[J].Optom Vis Sci,2011,88(4):476-482.
[24] TICAK A,WALLINE J J.Peripheral optics with bifocal soft and corneal reshaping contact lenses[J].Optom Vis Sci,2013,90(1):3-8.
[25] ZHOU X,ZHANG S,ZHANG G,CHEN Y,LEI Y,XIANG J,et al.Increased choroidal blood perfusion can inhibit form deprivation myopia in guinea pigs[J].Invest Opthalmol Vis Sci,2020,61(13):25.
[26] LEE J H,HONG I H,LEE T Y,HAN J R,JEON G S.Choroidal thickness changes after orthokeratology lens wearing in young adults with myopia[J].Ophthalmic Res,2021,64(1):121-127.
[27] CHAMBERLAIN P,PEIXOTO-DE-MATOS S C,LOGAN N S,NGO C,JONES D,YOUNG G.A 3-year randomized clinical trial of misight lenses for myopia control[J].Optom Vis Sci,2019,96(8):556-567.
[28] PRZEKORACKA K,MICHALAK K,OLSZEWSKI J,ZERI F,MICHALSKI A,PALUCH J,et al.Contrast sensitivity and visual acuity in subjects wearing multifocal contact lenses with high additions designed for myopia progression control[J].Cont Lens Anterior Eye,2020,43(1):33-39.
[29] GIFFORD K L.Childhood and lifetime risk comparison of myopia control with contact lenses[J].Cont Lens Anterior Eye,2020,43(1):26-32.
[30] BAO J,HUANG Y,LI X,YANG A,ZHOU F,WU J,et al.Spectacle lenses with aspherical lenslets for myopia control vs single-vision spectacle lenses:a randomized clinical trial[J].JAMA Ophthalmol,2022,140(5):472-478.
[31] LAM C S,TANG W C,LEE P H,ZHANG H Y,QI H,HASEGAWA K,et al.Myopia control effect of defocus incorporated multiple segments (DIMS) spectacle lens in Chinese children:results of a 3-year follow-up study[J].Br J Ophthalmol,2022,106(8):1110-1114.
[32] LAM C S Y,TANG W C,TSE D Y,LEE R P K,CHUN R K M,HASEGAWA K,et al.Defocus incorporated multiple segments (DIMS) spectacle lenses slow myopia progression:a 2-year randomised clinical trial[J].Br J Ophthalmol,2020,104(3):363-368.
[33] YEN M Y,LIU J H,KAO S C,SHIAO C H.Comparison of the effect of atropine and cyclopentolate on myopia[J].Ann Ophthalmol,1989,21(5):180-182,187.
[34] CHUA W H,BALAKRISHNAN V,CHAN Y H,TONG L,LING Y,QUAH B L,et al.Atropine for the treatment of childhood myopia[J].Ophthalmology,2006,113(12):2285-2291.
[35] CHIA A,CHUA W H,CHEUNG Y B,WONG W L,LINGHAM A,FONG A,et al.Atropine for the treatment of childhood myopia:safety and efficacy of 0.5%,0.1%,and 0.01%doses (atropine for the treatment of myopia 2)[J].Ophthalmology,2012,119(2):347-354.
[36] YAM J C,JIANG Y,TANG S M,LAW A K P,CHAN J J,WONG E,et al.Low-concentration atropine for myopia progression (LAMP) study:a randomized,double-blinded,placebo-controlled trial of 0.05%,0.025%,and 0.01%atropine eye drops in myopia control[J].Ophthalmology,2019,126(1):113-124.
[37] FOO L L,HTOON H,FAROOQUI S Z,CHIA A.Part-time use of 1%atropine eye drops for prevention of myopia progression in children[J].Int Ophthalmol,2020,40(7):1857-1862.
[38] BRENNAN N A,TOUBOUTI Y M,CHENG X,BULLIMORE M A.Efficacy in myopia control[J].Prog Retin Eye Res,2021,83:100923.
[39] ZHOU L,XING C,QIANG W,HUA C,TONG L.Low-intensity,long-wavelength red light slows the progression of myopia in children:an Eastern China-based cohort[J].Ophthalmic Physiol Opt,2022,42(2):335-344.
[40] JIANG Y,ZHU Z,TAN X,KONG X,ZHONG H,ZHANG J,et al.Effect of repeated low-level red-light therapy for myopia control in children:a multicenter randomized controlled trial[J].Ophthalmology,2022,129(5):509-519.
[41] HUGHES R P J,READ S A,COLLINS M J,VINCENT S J.Axial elongation during short-term accommodation in myopic and nonmyopic children[J].Invest Ophthalmol Vis Sci,2022,63(3):12.
[42] WU H,CHEN W,ZHAO F,ZHOU Q,REINACH P S,DENG L,et al.Scleral hypoxia is a target for myopia control[J].Proc Natl Acad Sci U S A,2018,115(30):E7091-E7100.
[43] XIONG F,MAO T,LIAO H,HU X,SHANG L,YU L,et al.Orthokeratology and low-intensity laser therapy for slowing the progression of myopia in children[J].Biomed Res Int,2021,2021:8915867.
[44] WANG S,WANG J,WANG N.Combined orthokeratology with atropine for Children with myopia:a meta-analysis[J].Ophthalmic Res,2021,64(5):723-731.